Aquestive Therapeutics (AQST) Operating Expenses (2017 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Operating Expenses of $18.6 million for Q1 2026, down 33.59% year-over-year from $28.1 million in Q1 2025, and down 55.44% quarter-over-quarter from $41.9 million in Q4 2025.
Aquestive Therapeutics (AQST) Operating Expenses (2017 - 2026) Analysis & Trends
Aquestive Therapeutics' Operating Expenses history runs 10 years deep, the most recent figure standing at $18.6 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 33.59% year-over-year to $18.6 million; the TTM figure through Mar 2026 stood at $106.2 million (up 11.27% YoY), while the FY2025 annual figure was $115.6 million, up 30.87% from the prior year.
- Operating Expenses for Q1 2026 stood at $18.6 million, down from $41.9 million in the prior quarter.
- The five-year high for Operating Expenses was $41.9 million in Q4 2025, with the low at $15.4 million in Q3 2023.
- The 5-year median for Operating Expenses is $21.4 million (2025), against an average of $22.2 million.
- The sharpest annual moves came in 2025 and 2026: Operating Expenses surged 64.48% in 2025, then slumped 33.59% in 2026.
- Aquestive Therapeutics' Operating Expenses stood at $21.4 million in 2022, then retreated by 20.0% to $17.1 million in 2023, then jumped by 48.66% to $25.4 million in 2024, then soared by 64.48% to $41.9 million in 2025, then plunged by 55.44% to $18.6 million in 2026.
- Business Quant data shows AQST's Operating Expenses at $18.6 million in Q1 2026, $41.9 million in Q4 2025, and $24.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Aquestive Therapeutics | 558.10 Mn | 558.10 Mn | 9.80 Mn | 22.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.04 Mn |
| Mar 31, 2026 | 18.65 Mn |
| Dec 31, 2025 | 41.85 Mn |
| Sep 30, 2025 | 24.29 Mn |
| Jun 30, 2025 | 21.37 Mn |
| Mar 31, 2025 | 28.09 Mn |
| Dec 31, 2024 | 25.45 Mn |
| Sep 30, 2024 | 21.83 Mn |
| Jun 30, 2024 | 20.04 Mn |
| Mar 31, 2024 | 21.01 Mn |
| Dec 31, 2023 | 17.12 Mn |
| Sep 30, 2023 | 15.38 Mn |
| Jun 30, 2023 | 17.45 Mn |
| Mar 31, 2023 | 15.74 Mn |
| Dec 31, 2022 | 21.40 Mn |
| Sep 30, 2022 | 20.32 Mn |
| Jun 30, 2022 | 26.03 Mn |
| Mar 31, 2022 | 22.01 Mn |
| Dec 31, 2021 | 22.75 Mn |
| Sep 30, 2021 | 21.26 Mn |